Comparative outcomes of endoscopic mucosal resection for laterally spreading lesions in inflammatory bowel disease
Endoscopy · 01.02.2025 · 57 (02) · 148-155
DOI: 10.1055/a-2369-7980 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift Endoscopy, erschienen am 01.02.2025. Verfasst von Varun T Angajala und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Division of Gastrointestinal and Liver Diseases, University of Southern California, Keck School of Medicine, Los Ang…. Hauptthemen laut MEDLINE: Endoscopic Mucosal Resection, Inflammatory Bowel Diseases, Neoplasm Recurrence, Local, Adenoma. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 18 Literaturangaben.
Abstract (Originalsprache)
Background
The role of endoscopic mucosal resection (EMR) for laterally spreading lesions (LSLs) in inflammatory bowel disease (IBD) remains controversial despite its effectiveness in the general population. We aimed to characterize outcomes of EMR for IBD-associated LSLs compared with controls without IBD.
Methods
We performed a retrospective observational cohort study of patients with IBD who underwent EMR and endoscopic follow-up for LSLs, compared with a control group without IBD. The primary outcome was histologic recurrence. Secondary outcomes included en bloc resection and adverse events. Factors associated with recurrence were identified using multivariate mixed effects logistic regression.
Results
210 premalignant lesions in 155 patients were included. By histology, 91.0% were adenoma/low grade dysplasia or sessile serrated lesions. Median (IQR) lesion size was 25 (12–30) mm in the IBD group and 20 (12–30) mm in the control group. Recurrence was detected in 30.4% of IBD-associated lesions (7/23) compared with 20.9% of controls (39/187; odds ratio [OR] 2.51, 95%CI 0.59–10.71). En bloc resection was less common in the IBD group (2/23 [8.7%], 95%CI 1.1–28.0) versus controls (106/187 [56.7%], 95%CI 50.4–65.2). After adjusting for lesion size and histology, recurrence appeared more common in patients with IBD compared with controls (OR 3.08, 95%CI 1.04–9.13).
Conclusions
Recurrence of LSLs after EMR appeared to be more frequent in patients with IBD. Given the added complexity, EMR in patients with IBD should be performed in expert centers with close endoscopic surveillance.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Internal Medicine, Division of Gastrointestinal and Liver Diseases, University of Southern California, Keck School of Medicine, Los Angeles, United States.
- Department of Population and Public Health Sciences, University of Southern California, Los Angeles, United States.
Zitieren
APA
Angajala, V. T., Buxbaum, J. L., Phan, J., Dodge, J. L., Mayemura, C., Ho, M., Lit, A., Tien, C., Chang, P. W., Amini, M., Sheibani, S., & Sahakian, A. B. (2025). Comparative outcomes of endoscopic mucosal resection for laterally spreading lesions in inflammatory bowel disease. Endoscopy, 57(02), 148-155. https://doi.org/10.1055/a-2369-7980
Vancouver
Angajala VT, Buxbaum JL, Phan J, Dodge JL, Mayemura C, Ho M, et al. Comparative outcomes of endoscopic mucosal resection for laterally spreading lesions in inflammatory bowel disease. Endoscopy. 2025;57(02):148-155. doi:10.1055/a-2369-7980
BibTeX
@article{Angajala2025,
author = {Angajala, Varun T and Buxbaum, James L and Phan, Jennifer and Dodge, Jennifer L and Mayemura, Collin and Ho, Melissa and Lit, Aaron and Tien, Christine and Chang, Patrick W and Amini, Maziar and Sheibani, Sarah and Sahakian, Ara B},
title = {Comparative outcomes of endoscopic mucosal resection for laterally spreading lesions in inflammatory bowel disease},
journal = {Endoscopy},
year = {2025},
volume = {57},
number = {02},
pages = {148--155},
doi = {10.1055/a-2369-7980}
}
EUVIMED